| Literature DB >> 33110575 |
Johanna Nice1, Honelgn Nahusenay1, Erin Eckert2,3, Thomas P Eisele4, Ruth A Ashton1.
Abstract
BACKGROUND: Accurate estimation of intervention coverage is a vital component of malaria program monitoring and evaluation, both for process evaluation (how well program targets are achieved), and impact evaluation (whether intervention coverage had an impact on malaria burden). There is growing interest in maximizing the utility of program data to generate interim estimates of intervention coverage in the periods between large-scale cross-sectional surveys (the gold standard). As such, this study aimed to identify relevant concepts and themes that may guide future optimization of intervention coverage estimation using routinely collected data, or data collected during and following intervention campaigns, with a particular focus on strategies to define the denominator.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33110575 PMCID: PMC7568932 DOI: 10.7189/jogh.10.020413
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Figure 1PRISMA flow diagram for studies assessing malaria intervention coverage 2015-2018.
Challenges in coverage estimation using program data and/or post-campaign surveys
| Seasonal Malaria Chemoprevention (SMC) | Mass Drug Administration (MDA) | Intermittent preventive treatment in pregnancy (IPTp) | Indoor Residual Spray (IRS) | |
|---|---|---|---|---|
| • SMC coverage using program records only includes ingestion of the day 1 dose of SP+AQ, not completion of the full 3-d course of chemoprevention. | • MDA coverage often uses only data relating to ingestion of the day 1 dose, not completion of the full course of MDA.
• Estimating coverage is particularly difficult if drugs are provided at distribution point to household representatives, rather than to individual household members. | • Survey-based estimates may underestimate IPTp coverage by limiting to receipt of SP from 'skilled providers' only, and are subject to recall bias.
• Routine monitoring data may not capture the updated WHO recommendation that women receive at least three rounds of IPTp. | • Poorly demarcated target boundaries affect IRS implementation and coverage estimates.
• The relevant time period for recall of IRS varies according to the insecticide used. | |
| • If SMC cards are used, retention of these cards should be reported in coverage surveys, as well as coverage according to data on these cards. | • Specify coverage estimates relate to day 1 dose only.
• Amend MDA strategy to DOT on all doses, resources permitting.
• Check drug blister packets during post-campaign surveys to estimate proportion ingesting all doses. | • Electronic data systems at ANC clinic could facilitate linkage of data from each ANC visit. | • Spatial aids may assist in accurate identification of spray-targeted areas on the ground.
• Surveys including IRS recall questions should be cognizant of insecticide used and effective period. | |
| • Denominator may change from start to end of SMC period, some families may not remain resident for the whole period.
• Off-target distribution of SMC is common. | • Census denominators may not be up to date, particularly in urban areas which tend to have higher growth rates.
• Population denominators do not always state whether they include ineligible individuals (eg, pregnant women).
• While local leaders can assist in validating population estimates, this may not be effective for incorporation of minority or mobile populations. | • Wide range of denominators presented in the literature when estimating IPTp coverage.
• Population denominators often do not state whether they include ineligible individuals (eg, receipt of co-trimoxazole). | • Program coverage denominator is often “number of structures found by spray team,” which may not capture all target structures.
• Migrant and mobile populations may be missing from denominators. | |
| • Any cross-sectional post-campaign surveys should include children beyond the target age range, to estimate intervention coverage among older children. | • Triangulating denominator estimates from multiple sources, or validating by micro-census can assist in generating feasible ranges for the denominator. | • Use of ANC visit 1 as a denominator could aid understanding of IPTp uptake among ANC attendees. | • Clear definition of either household or structure as denominator. • Satellite imagery can assist in enumeration of target areas. |
ANC – antenatal care; DOT – directly observed treatment; IPTp – intermittent preventive treatment in pregnancy; IRS – indoor residual spray; MDA – mass drug administration; SMC – seasonal malaria chemoprevention; SP – sulfadoxine-pyrimethamine; SP+AQ – sulfadoxine-pyrimethamine and amodiaquine; WHO – World Health Organization